Universal Prophylaxis, Targeted Prophylaxis, and/or Preemptive Therapy for Opportunistic Infections at the Time of Initiation of Combination Antiretroviral Therapy for Patients with Advanced HIV Infection

被引：4
|
作者：
DiNubile, Mark J. [1 ]
机构：
[1] Merck Res Labs, N Wales, PA 19454 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2009年 / 49卷 / 05期
关键词：
RECONSTITUTION INFLAMMATORY SYNDROME; CLINICAL-DISEASE PROGRESSION; GAMMA RELEASE ASSAY; IMMUNE RECONSTITUTION; HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; CRYPTOCOCCAL ANTIGENEMIA; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; TUBERCULOSIS;
D O I：
10.1086/605289
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：808 / U168
页数：5
相关论文
共 50 条
  • [1] Universal Prophylaxis, Targeted Prophylaxis, and/or Preemptive Therapy for Opportunistic Infections at the Time of Initiation of Combination Antiretroviral Therapy for Patients with Advanced HIV Infection Reply
    Srasuebkul, Preeyaporn
    Sungkanuparph, Somnuek
    Lim, Poh Lian
    Law, Matthew G.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 811 - U170
  • [2] Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy
    Jubault, V
    Pacanowski, J
    Rabian, C
    Viard, JP
    ANNALES DE MEDECINE INTERNE, 2000, 151 (03): : 163 - 168
  • [3] Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy
    Powderly, WG
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) : 597 - 601
  • [4] Preemptive therapy versus universal prophylaxis: Time for reconciliation?
    Kampouri, Eleftheria
    Manuel, Oriol
    TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (02)
  • [5] Prophylaxis of opportunistic infections in the era of potent antiretroviral therapy: an update
    Aberg, JA
    FORMULARY, 1999, 34 (05) : 418 - +
  • [6] Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
    Hakim, J.
    Musiime, V.
    Szubert, A. J.
    Mallewa, J.
    Siika, A.
    Agutu, C.
    Walker, S.
    Pett, S. L.
    Bwakura-Dangarembizi, M.
    Lugemwa, A.
    Kaunda, S.
    Karoney, M.
    Musoro, G.
    Kabahenda, S.
    Nathoo, K.
    Maitland, K.
    Griffiths, A.
    Thomason, M. J.
    Kityo, C.
    Mugyenyi, P.
    Prendergast, A. J.
    Walker, A. S.
    Gibb, D. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (03): : 233 - 245
  • [7] PROPHYLAXIS OF OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HIV-INFECTION
    CARR, A
    PENNY, R
    COOPER, DA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 : S56 - S60
  • [8] PROPHYLAXIS FOR OPPORTUNISTIC INFECTIONS IN PATIENTS WITH HIV-INFECTION
    GALLANT, JE
    MOORE, RD
    CHAISSON, RE
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) : 932 - 944
  • [9] Discontinuation of prophylaxis for HIV-associated opportunistic infections in the era of highly active antiretroviral therapy
    Hermsen, ED
    Wynn, HE
    McNabb, J
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (03) : 245 - 256
  • [10] Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy
    Soriano, V
    Dona, C
    Rodríguez-Rosado, R
    Barreiro, P
    González-Lahoz, J
    AIDS, 2000, 14 (04) : 383 - 386
12345